Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic

Market Cap

$141.21 Million

₹12.23 Billion INR

Market Cap Rank

#19867 Global

#989 in India

Share Price

₹914.90

Change (1 day)

+0.35%

52-Week Range

₹279.45 - ₹927.50

All Time High

₹927.50

Venus Remedies Limited - Asset Resilience Ratio

Latest as of September 2025: 30.75%

Venus Remedies Limited (VENUSREM) has an Asset Resilience Ratio of 30.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₹2.36 Billion

Cash + Short-term Investments

Total Assets

₹7.68 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Venus Remedies Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Venus Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₹219.90 Million	2.86%
Short-term Investments	₹2.14 Billion	27.89%
Total Liquid Assets	₹2.36 Billion	30.75%

Asset Resilience Insights

Very High Liquidity: Venus Remedies Limited maintains exceptional liquid asset reserves at 30.75% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.